is there still a glp-1 shortage FDA says that the over How FDA Crackdowns Are Affecting
Description
Larger peptide-based compounds, like GLP-1 medications, cannot get through without special technology like microneedles or chemical enhancers
.png)
The answer lies in the psychology of diabetes

Ill attach a table comparing stroke outcomes from major GLP-1 trials like SUSTAIN-6, REWIND, LEADER, and more

I preferred it

On the other hand, 40% of the states that do cover GLP-1 drugs -- or are weighing coverage -- noted that the meds could ultimately save money by heading off the chronic diseases associated with obesity

Takahashi T, Shiraishi A
